2019冠状病毒病对医院抗生素使用的影响

Ling Foo Seng
{"title":"2019冠状病毒病对医院抗生素使用的影响","authors":"Ling Foo Seng","doi":"10.51200/bjms.v17i.4316","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has disrupted antimicrobial stewardship (AMS) activities in Hospital Queen Elizabeth II (HQEII), which has led to a surge in antibiotics consumption, particularly meropenem, vancomycin, piperacillin-tazobactam, ceftazidime, and ceftriaxone. This study aimed to compare the prevalence of antibiotics consumption in HQEII before (2018/2019) and during (2020/2021) the pandemic to explore its impact on antibiotic costs and bacterial resistance.","PeriodicalId":9287,"journal":{"name":"Borneo Journal of Medical Sciences (BJMS)","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of COVID-19 Towards Antibiotics Consumption in Hospital Queen Elizabeth II\",\"authors\":\"Ling Foo Seng\",\"doi\":\"10.51200/bjms.v17i.4316\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 pandemic has disrupted antimicrobial stewardship (AMS) activities in Hospital Queen Elizabeth II (HQEII), which has led to a surge in antibiotics consumption, particularly meropenem, vancomycin, piperacillin-tazobactam, ceftazidime, and ceftriaxone. This study aimed to compare the prevalence of antibiotics consumption in HQEII before (2018/2019) and during (2020/2021) the pandemic to explore its impact on antibiotic costs and bacterial resistance.\",\"PeriodicalId\":9287,\"journal\":{\"name\":\"Borneo Journal of Medical Sciences (BJMS)\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Borneo Journal of Medical Sciences (BJMS)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51200/bjms.v17i.4316\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Borneo Journal of Medical Sciences (BJMS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51200/bjms.v17i.4316","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2019冠状病毒病大流行扰乱了伊丽莎白女王二世医院的抗微生物药物管理活动,导致抗生素消费量激增,特别是美罗培南、万古霉素、哌拉西林-他唑巴坦、头孢他啶和头孢曲松。本研究旨在比较大流行前(2018/2019年)和期间(2020/2021年)HQEII抗生素消费的流行情况,以探讨其对抗生素成本和细菌耐药性的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of COVID-19 Towards Antibiotics Consumption in Hospital Queen Elizabeth II
The COVID-19 pandemic has disrupted antimicrobial stewardship (AMS) activities in Hospital Queen Elizabeth II (HQEII), which has led to a surge in antibiotics consumption, particularly meropenem, vancomycin, piperacillin-tazobactam, ceftazidime, and ceftriaxone. This study aimed to compare the prevalence of antibiotics consumption in HQEII before (2018/2019) and during (2020/2021) the pandemic to explore its impact on antibiotic costs and bacterial resistance.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信